NYSE: AHR · Healthcare Facility REITs
American Healthcare REIT (AHR) fair value and price range
As of 26 Sep 2026, Faircurve's model values American Healthcare REIT (AHR) at $23.10 a share. The stock last closed at $50.75, which puts the model's fair value 54.5% below the price. The model grades the evidence behind this valuation as low, so no verdict is shown. For real estate investment trusts (REITs) the grade looks at how many valuation methods could be applied and whether they agree with each other, and how many comparable companies there are. It does not say how likely the fair value is to be right.
Revalued . Price is the close of 2 Oct 2026. American Healthcare REIT, Inc.
Faircurve Insights · 26 Sep 2026
American Healthcare REIT, Inc. was forged through a significant strategic consolidation, combining Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, along with integrating the business and operations of American Healthcare. It is a real estate investment trust focused on healthcare facilities.
Faircurve's model on 26 Sep 2026 gave a fair value of $23.10 a share. This fair value blends a cash-flow multiple against comparable companies, a dividend model, and the value of the properties. The previous run, on 19 Sep 2026, gave $23.42, so the fair value moved -1.4%. The model's calibrated range over 63 trading days is $19.38 to $28.17; ranges built this way held the price 60% of the time at this horizon. The model grades the evidence behind this valuation as low.
The model compares American Healthcare REIT, Inc. with CareTrust REIT, Inc., Omega Healthcare Investors, Inc., Healthpeak Properties, Inc., Healthcare Realty Trust Incorporated, Sabra Health Care REIT, Inc., Ventas, Inc., LTC Properties, Inc., and Medical Properties Trust, Inc. Around its last 8 earnings reports, the stock moved +2.2% on 6 Aug 2026, +3.4% on 7 May 2026, -1.3% on 26 Feb 2026, +4.9% on 6 Nov 2025, +2.2% on 7 Aug 2025, +25.9% on 8 May 2025, +0.2% on 27 Feb 2025, and +1.2% on 12 Nov 2024.
Written from the figures on this page for the 26 Sep 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
What price range does the model give AHR?
The calibrated range for AHR over 63 trading days is $19.38 to $28.17. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 4,327 past valuations, refreshed 26 Sep 2026). Ranges built this way held the price 60% of the time at this horizon.
The price is above this range. For names with fair value 15%+ below price, the calibrated range has held the price 40% of the time over 63 trading days, and 58% ended above it; the typical move was −0.1%.
The model's own range is $21.44 to $24.95.
How does AHR compare with similar companies?
The companies in healthcare facility reits closest to American Healthcare REIT in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| CTRE CareTrust REIT, Inc. | $36.30 | $31.40 | -13.5% | No verdict on this run |
| OHI Omega Healthcare Investors, Inc. | $45.72 | $53.51 | +17.0% | No verdict on this run |
| DOC Healthpeak Properties, Inc. | $19.49 | $24.21 | +24.2% | Low evidence grade |
| HR Healthcare Realty Trust Incorporated | $17.47 | $16.25 | -7.0% | No verdict on this run |
| SBRA Sabra Health Care REIT, Inc. | $19.16 | $16.29 | -15.0% | No verdict on this run |
| VTR Ventas, Inc. | $84.01 | $42.67 | -49.2% | No verdict on this run |
| LTC LTC Properties, Inc. | $43.00 | $43.30 | +0.7% | Low evidence grade |
| MPT Medical Properties Trust, Inc. | $3.27 | $4.39 | +34.3% | Low evidence grade |
All healthcare facility reit stocks ranked by gap to fair value
When does AHR report earnings, and how has the stock reacted?
American Healthcare REIT's next earnings report is scheduled for 5 Nov 2026. Companies can move their dates.
How AHR moved around its last 8 earnings reports
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across these 8 reports, ignoring direction, was 2.2%.
| Report date | Two session move |
|---|---|
| 6 Aug 2026 | +2.2% |
| 7 May 2026 | +3.4% |
| 26 Feb 2026 | -1.3% |
| 6 Nov 2025 | +4.9% |
| 7 Aug 2025 | +2.2% |
| 8 May 2025 | +25.9% |
| 27 Feb 2025 | +0.2% |
| 12 Nov 2024 | +1.2% |
American Healthcare REIT at a glance
American Healthcare REIT (AHR) was forged through a significant strategic consolidation, combining Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, along with integrating the business and operations of American Healthcare.
- Market value
- $10.8B
- Sector
- Real Estate
- Industry
- Healthcare Facility REITs
- Beta to the US market
- -0.05
- First valued by Faircurve
- 11 Jul 2026
How the fair value is worked out: the model values American Healthcare REIT three ways and blends them; the range around the fair value comes from 2,000 simulations of the dividend model. The full method is documented here.
What changed in the latest valuation?
On 19 Sep 2026 the model's fair value for AHR was $23.42. As of 26 Sep 2026 it is $23.10, a change of -1.4%. The model revalues every stock it covers each week, and again after an earnings report.
Questions about American Healthcare REIT's valuation
Is American Healthcare REIT stock undervalued or overvalued?
Faircurve's model puts AHR's fair value at $23.10 a share against a last close of $50.75, as of 26 Sep 2026. The model grades the evidence behind this valuation as low, so no verdict is shown. For real estate investment trusts (REITs) the grade looks at how many valuation methods could be applied and whether they agree with each other, and how many comparable companies there are. It does not say how likely the fair value is to be right.
What is AHR's fair value?
$23.10 a share as of 26 Sep 2026. The fair value blends three methods: a cash-flow multiple against comparable companies, a dividend model, and the value of the properties. The model's own range is $21.44 to $24.95.
What price range does the model give AHR?
$19.38 to $28.17 over 63 trading days. Ranges built this way held the price 60% of the time across 4,327 past valuations, refreshed 26 Sep 2026.
When does American Healthcare REIT report earnings next?
The next report is scheduled for 5 Nov 2026. Companies can move their dates.
How much has AHR moved on past earnings reports?
Across its last 8 reports the median two session move was 2.2%, ignoring direction. The largest was +25.9% around the report of 8 May 2025.
How confident is the model in this valuation?
The model's evidence grade for AHR is low. For real estate investment trusts (REITs) the grade looks at how many valuation methods could be applied and whether they agree with each other, and how many comparable companies there are. It is not a probability that the fair value is right, or that the price reaches it.